title: Transcriptome profiles associated to VHSV infection or DNA vaccination in turbot (Scophthalmus maximus).
abstract: DNA vaccines encoding the viral G glycoprotein show the most successful protection capability against fish rhabdoviruses. Nowadays, the molecular mechanisms underlying the protective response remain still poorly understood. With the aim of shedding light on the protection conferred by the DNA vaccines based in the G glycoprotein of viral haemorrhagic septicaemia virus (VHSV) in turbot (Scophthalmus maximus) we have used a specific microarray highly enriched in antiviral sequences to carry out the transcriptomic study associated to VHSV DNA vaccination/infection. The differential gene expression pattern in response to empty plasmid (pMCV1.4) and DNA vaccine (pMCV1.4-G860) intramuscular administration with regard to non-stimulated turbot was analyzed in head kidney at 8, 24 and 72 hours post-vaccination. Moreover, the effect of VHSV infection one month after immunization was also analyzed in vaccinated and non-vaccinated fish at the same time points. Genes implicated in the Toll-like receptor signalling pathway, IFN inducible/regulatory proteins, numerous sequences implicated in apoptosis and cytotoxic pathways, MHC class I antigens, as well as complement and coagulation cascades among others were analyzed in the different experimental groups. Fish receiving the pMCV1.4-G860 vaccine showed transcriptomic patterns very different to the ones observed in pMCV1.4-injected turbot after 72 h. On the other hand, VHSV challenge in vaccinated and non-vaccinated turbot induced a highly different response at the transcriptome level, indicating a very relevant role of the acquired immunity in vaccinated fish able to alter the typical innate immune response profile observed in non-vaccinated individuals. This exhaustive transcriptome study will serve as a complete overview for a better understanding of the crosstalk between the innate and adaptive immune response in fish after viral infection/vaccination. Moreover, it provides interesting clues about molecules with a potential use as vaccine adjuvants, antiviral treatments or markers for vaccine efficiency monitoring.
authors.affiliation: Instituto de Investigaciones Marinas (IIM), CSIC, Vigo, Spain.
authors.forename: Patricia
authors.initials: P
authors.lastname: Pereiro
authors.affiliation: Instituto de Investigaciones Marinas (IIM), CSIC, Vigo, Spain.
authors.forename: Sonia
authors.initials: S
authors.lastname: Dios
authors.affiliation: Institute of Aquaculture, University of Stirling, Stirling, Scotland, United Kingdom; Institut de Biotecnologia i de Biomedicina, Universitat Autònoma de Barcelona, Barcelona, Spain.
authors.forename: Sebastián
authors.initials: S
authors.lastname: Boltaña
authors.affiliation: Dpto Biotecnología, Instituto Nacional Investigaciones Agrarias (INIA), Madrid, Spain.
authors.forename: Julio
authors.initials: J
authors.lastname: Coll
authors.affiliation: Instituto de Biología Molecular y Celular (IBMC), Miguel Hernández University, Elche, Spain.
authors.forename: Amparo
authors.initials: A
authors.lastname: Estepa
authors.affiliation: Institute of Aquaculture, University of Stirling, Stirling, Scotland, United Kingdom; Institut de Biotecnologia i de Biomedicina, Universitat Autònoma de Barcelona, Barcelona, Spain.
authors.forename: Simon
authors.initials: S
authors.lastname: Mackenzie
authors.affiliation: Instituto de Investigaciones Marinas (IIM), CSIC, Vigo, Spain.
authors.forename: Beatriz
authors.initials: B
authors.lastname: Novoa
authors.affiliation: Instituto de Investigaciones Marinas (IIM), CSIC, Vigo, Spain.
authors.forename: Antonio
authors.initials: A
authors.lastname: Figueras
mesh_terms: D000818:Animals; D005393:Fish Diseases / Q000378:metabolism / Q000517:prevention & control; D005412:Flatfishes; D029141:Novirhabdovirus; D018353:Rhabdoviridae Infections / Q000378:metabolism / Q000517:prevention & control / Q000662:veterinary; D059467:Transcriptome / Q000187:drug effects*; D019444:Vaccines, DNA / Q000494:pharmacology*; D014765:Viral Vaccines / Q000494:pharmacology*
chemical_list: D019444:Vaccines, DNA; D014765:Viral Vaccines
references.citation: J Biol Chem. 2007 May 25;282(21):15319-23
references.pmid: 17395581
references.citation: Biol Proced Online. 2006;8:175-93
references.pmid: 17242735
references.citation: Hum Pathol. 2010 Feb;41(2):271-80
references.pmid: 20004001
references.citation: Dev Comp Immunol. 2014 Aug;45(2):233-44
references.pmid: 24680948
references.citation: Immunology. 2004 Jul;112(3):345-51
references.pmid: 15196201
references.citation: Mol Immunol. 2006 May;43(13):2089-106
references.pmid: 16426680
references.citation: Nat Rev Immunol. 2006 Sep;6(9):644-58
references.pmid: 16932750
references.citation: J Virol. 2003 Nov;77(21):11471-9
references.pmid: 14557632
references.citation: Clin Exp Immunol. 2002 Dec;130(3):501-8
references.pmid: 12452842
references.citation: J Immunol. 2012 Sep 15;189(6):2717-21
references.pmid: 22896636
references.citation: Trends Microbiol. 1998 Jan;6(1):23-7
references.pmid: 9481820
references.citation: Methods Mol Biol. 2000;132:365-86
references.pmid: 10547847
references.citation: J Immunol. 2010 Nov 1;185(9):5628-36
references.pmid: 20870944
references.citation: Clin Microbiol Rev. 2009 Apr;22(2):240-73, Table of Contents
references.pmid: 19366914
references.citation: Infect Immun. 1983 Jan;39(1):7-14
references.pmid: 6822436
references.citation: J Virol. 1980 Dec;36(3):652-8
references.pmid: 6780698
references.citation: J Biol Chem. 2011 Feb 11;286(6):4517-24
references.pmid: 21131352
references.citation: J Gen Virol. 1990 Mar;71 ( Pt 3):561-7
references.pmid: 1690259
references.citation: Blood. 1992 Nov 1;80(9):2363-73
references.pmid: 1421407
references.citation: J Virol. 2000 Aug;74(15):7048-54
references.pmid: 10888644
references.citation: Vaccine. 2006 Feb 13;24(7):921-30
references.pmid: 16185791
references.citation: Immunology. 2003 Oct;110(2):163-9
references.pmid: 14511229
references.citation: Inflamm Res. 2000 May;49(5):199-205
references.pmid: 10893042
references.citation: J Exp Med. 1992 Jul 1;176(1):287-92
references.pmid: 1613462
references.citation: Fish Shellfish Immunol. 2005 Jul;19(1):27-41
references.pmid: 15722229
references.citation: Cytokine Growth Factor Rev. 2001 Mar;12(1):53-72
references.pmid: 11312119
references.citation: J Gen Virol. 1994 Jul;75 ( Pt 7):1579-87
references.pmid: 8021589
references.citation: Nat Immunol. 2010 May;11(5):373-84
references.pmid: 20404851
references.citation: Chest. 1998 Dec;114(6):1681-8
references.pmid: 9872206
references.citation: Cell Death Differ. 2001 Feb;8(2):113-26
references.pmid: 11313713
references.citation: Proc Natl Acad Sci U S A. 1996 Mar 19;93(6):2588-92
references.pmid: 8637918
references.citation: PLoS Negl Trop Dis. 2012;6(2):e1519
references.pmid: 22389734
references.citation: J Thromb Haemost. 2003 Jul;1(7):1343-8
references.pmid: 12871267
references.citation: Comp Immunol Microbiol Infect Dis. 2011 Mar;34(2):103-10
references.pmid: 20371118
references.citation: J Virol. 2008 Sep;82(17):8246-52
references.pmid: 18448533
references.citation: Fish Shellfish Immunol. 2007 Sep;23(3):531-41
references.pmid: 17449275
references.citation: PLoS One. 2012;7(5):e35369
references.pmid: 22629298
references.citation: Front Biosci (Landmark Ed). 2009 Jan 01;14:3988-93
references.pmid: 19273328
references.citation: J Am Soc Nephrol. 2006 Jul;17(7):1807-19
references.pmid: 16738015
references.citation: Fish Shellfish Immunol. 2012 Jun;32(6):1088-94
references.pmid: 22554577
references.citation: Vaccine. 2011 Feb 1;29(6):1289-96
references.pmid: 21134453
references.citation: Nat Rev Immunol. 2002 Oct;2(10):735-47
references.pmid: 12360212
references.citation: Vet Res. 1995;26(5-6):379-87
references.pmid: 8581010
references.citation: Bioinformatics. 2005 Sep 15;21(18):3674-6
references.pmid: 16081474
references.citation: Nucleic Acids Res. 2001 May 1;29(9):e45
references.pmid: 11328886
references.citation: J Gen Virol. 2000 Oct;81(Pt 10):2341-2364
references.pmid: 10993923
references.citation: Vaccine. 2008 Feb 6;26(6):837-44
references.pmid: 18191880
references.citation: Dev Comp Immunol. 2011 Dec;35(12):1376-87
references.pmid: 21781984
references.citation: Gene Ther. 2003 Sep;10(18):1592-9
references.pmid: 12907951
references.citation: Vaccine. 2003 Dec 1;21(32):4661-7
references.pmid: 14585673
references.citation: J Interferon Cytokine Res. 2011 Jan;31(1):71-8
references.pmid: 20950130
references.citation: Eur Cytokine Netw. 2006 Dec;17(4):224-52
references.pmid: 17353157
references.citation: Vet Immunol Immunopathol. 1998 Apr 30;62(4):359-66
references.pmid: 9646440
references.citation: Fish Shellfish Immunol. 2005 Feb;18(2):135-47
references.pmid: 15475310
references.citation: Microb Pathog. 1990 Nov;9(5):293-301
references.pmid: 2099382
references.citation: Cardiovasc Res. 2003 Oct 15;60(1):26-39
references.pmid: 14522404
references.citation: Br Med Bull. 1985 Jan;41(1):15-21
references.pmid: 3882185
references.citation: Rev Sci Tech. 2005 Apr;24(1):201-13
references.pmid: 16110889
references.citation: Nature. 2006 May 4;441(7089):101-5
references.pmid: 16625202
references.citation: Nat Immunol. 2004 Oct;5(10):981-6
references.pmid: 15454921
references.citation: EMBO J. 2000 Jul 3;19(13):3325-36
references.pmid: 10880445
references.citation: Immunol Rev. 2004 Jun;199:201-16
references.pmid: 15233736
references.citation: Antiviral Res. 2007 Jul;75(1):43-51
references.pmid: 17194487
references.citation: Open Microbiol J. 2008;2:49-59
references.pmid: 19088911
references.citation: Vaccine. 2001 Jul 16;19(28-29):4011-9
references.pmid: 11427277